Profound Medical Newsroom

Profound Medical Upgraded at Stifel on Medicare Policy Update

Seeking AlphaJul 16 14:46 ET

Profound Medical Analyst Ratings

BenzingaJul 16 05:31 ET

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

BenzingaJul 16 05:30 ET

Buy Rating Affirmed for Profound Medical on Reimbursement and Market Expansion Prospects

TipRanksJul 15 17:27 ET

Profound Medical Analyst Ratings

BenzingaMar 11 10:34 ET

Profound Medical Analyst Ratings

BenzingaMar 8 10:47 ET

Profound Medical Analyst Ratings

BenzingaJan 4 09:01 ET

Stifel Starts Coverage of Profound Medical With Hold Rating

Seeking AlphaDec 1, 2023 15:27 ET

Stifel Initiates Coverage On Profound Medical With Hold Rating, Announces Price Target of $11

BenzingaNov 28, 2023 04:22 ET

Profound Medical Analyst Ratings

BenzingaNov 28, 2023 04:21 ET

Lake Street Reiterates Their Buy Rating on Profound Medical (PRN)

TipRanksNov 3, 2023 09:00 ET

Lake Street Maintains Their Buy Rating on Profound Medical (PRN)

TipRanksOct 16, 2023 09:10 ET

Lake Street Maintains a Buy Rating on Profound Medical (PRN)

TipRanksAug 10, 2023 09:20 ET

Profound Medical Analyst Ratings

BenzingaAug 4, 2023 08:48 ET

TD Cowen Adjusts Profound Medical Price Target to $18 From $14, Maintains Outperform Rating

MT NewswiresMay 11, 2023 07:43 ET

Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

BenzingaMay 11, 2023 06:48 ET

Jefferies Downgrades Profound Medical to Equal-Weight, Raises Price Target to $10

BenzingaMar 21, 2023 05:38 ET

Profound Medical Analyst Ratings

Benzinga Analyst RatingsNov 4, 2022 14:57 ET

Profound Medical Corp Is Maintained at Outperform by Raymond James

Dow JonesAug 8, 2022 12:40 ET

Profound Medical Corp. Is Maintained at Outperform by Raymond James

Dow JonesJul 18, 2022 14:01 ET